h
PSC
reg
®
Home
Browse
All cell lines
All hiPSC lines
All hESC lines
Cell line providers
Research projects
Countries
Diseases
Publications
Clinical studies
Info
About hPSCreg
FAQ
Cell Registration
Glossary
Documents & Governance
Fact Sheets
Naming Tool
Publishing your line
Structures
Registration Summary
Certification
Organoids
API
Export Data
SPARQL Guide
Contact
News
Newsletter Subscription
Privacy Policy
Terms of Use
Imprint
Login
Log-in
Sign up
Forgot your password?
This website uses cookies to keep track of login sessions and for internal Matomo Statistics. See our
Privacy Policy
for details.
This website uses cookies,
learn more
x
INMi002-A
Registration Summary
:
A
P
E
C
USH2A-USH-iPSC
The cell line is
not submitted
yet.
(only basic data is shown)
General
Cell Line
hPSCreg name
INMi002-A
Cite as:
When citing this cell line, please use the hPSCreg name (see
Naming Tool
) and the corresponding Research Resource ID (RRID).
INMi002-A (RRID:CVCL_UJ76)
Alternative name(s)
USH2A-USH-iPSC
Cell line type
Human induced pluripotent stem cell (hiPSC)
Similar lines
No similar lines found.
Last update
14th September 2018
User feedback
show/hide
Written by
on
Delete
No feedback available yet.
Login
to share your feedback, experiences or results with the research community.
Provider
Generator
Institute for Neurosciences of Montpellier (INM)
External Databases
Cellosaurus
CVCL_UJ76
Wikidata
Q94317989
General Information
Publications
Sanjurjo-Soriano C et al. Generation of a human iPSC line, INMi002-A, carrying the most prevalent USH2A variant associated with Usher syndrome type 2. Stem cell research. 2018 Dec;33:247-250.
Erkilic N et al. A Novel Chromosomal Translocation Identified due to Complex Genetic Instability in iPSC Generated for Choroideremia. Cells. 2019 Sep 11;8(9).
Sanjurjo-Soriano C et al. Genome Editing in Patient iPSCs Corrects the Most Prevalent USH2A Mutations and Reveals Intriguing Mutant mRNA Expression Profiles. Molecular therapy. Methods & clinical development. 2020 Jun 12;17:156-173.
Liu X et al. Generation and Genetic Correction of USH2A c.2299delG Mutation in Patient-Derived Induced Pluripotent Stem Cells. Genes. 2021 May 25;12(6).
Zaw K et al. Pathogenesis and Treatment of Usher Syndrome Type IIA. Asia-Pacific journal of ophthalmology (Philadelphia, Pa.). 2022 Jul-Aug 01;11(4):369-379.
Durán-Alonso MB et al. Induced Pluripotent Stem Cells, a Stepping Stone to In Vitro Human Models of Hearing Loss. Cells. 2022 Oct 21;11(20).
Sanjurjo-Soriano Carla et al. USH2A variants causing retinitis pigmentosa or Usher syndrome provoke differential retinal phenotypes in disease-specific organoids. Human Genetics and Genomics Advances. 2023-10-00.
Chen Yi et al. The occurrence and development of induced pluripotent stem cells. Frontiers in Genetics. 2024-04-18.
hIPSC Derivation
General
Login to share your feedback, experiences or results with the research community.